Persistence of Antibody Response to N. Meningitidis Group C in Children

Clinical trial NCT00316654 · COMPLETED

Trial details

NCT number: NCT00316654
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Prevention of Meningococcal Infection

Start date: 2005-02-01
Primary completion: 2005-10-01
Enrollment: 489

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.